Impl investor relations
WitrynaImpel Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, March 24, 2024. SEATTLE, March 17, 2024 (GLOBE NEWSWIRE) — Impel … Witryna2 mar 2024 · Contact Investor Relations. Direct [USA +1] 858-952-7593 E-mail [email protected]. ... 8:00am - 5:00pm EST. Cardiff Oncology management will participate in a corporate panel discussion and 1x1 investor meetings at the TD Cowen 43rd Annual Health Care Conference, which is taking place at the Boston... B. Riley …
Impl investor relations
Did you know?
Witryna2 dni temu · IMPL US45258K1097. IMPEL PHARMACEUTICALS INC. (IMPL) Add to my list. Report. Delayed ... Investor Relations Janhavi Mohite Stern Investor Relations Phone: 212-362-1200 Email: [email protected]. All news about IMPEL PHARMACEUTICALS INC. 04:09p: Witryna13 cze 2024 · This section contains both current and archived webcasts and presentations of Daré Bioscience, Inc. The information available in this section should be considered together with the other information available in Daré’s filings with the U.S. Securities and Exchange Commission, including its recent annual and quarterly …
WitrynaThe Investor Relations website contains information about Mission Produce, Inc.'s business for stockholders, potential investors, and financial analysts. WitrynaInvestor Calendar; Presentations; Financials. SEC Filings; Quarterly Results; Governance. Governance Highlights; Leadership; Board of Directors; Committee …
WitrynaQuarterly Reports. 4th Quarter. Press Release. Presentation. Earnings Terminology. View HTML Release and Related Photos. Transcript – Management Call. 3rd Quarter. Press Release. WitrynaInvestor Contacts; Email Alerts; Careers; Contact Events & Presentations. Events & Presentations Corporate Presentation Apr 01, 2024. April 2024 Corporate Presentation 5.4 MB. Upcoming Events More events are coming soon. Past Events 27 Mar. 2024 GAMIDA CELL Q4 2024 FINANCIAL RESULTS CALL ...
WitrynaOur Investment Case ... Download Read online. Investor Contacts. Raghav Gupta-Chaudhary. Investor Relations Director +44 (0)20 7546 8235 [email protected] …
WitrynaCorporate Profile. Alpine is a clinical-stage specialty pharmaceutical company focused on discovering and developing protein-based immunotherapies targeting the immune … simplify grove parkWitryna1 mar 2024 · Global Ship Lease Investor Presentation - Q4 2024 2.3 MB. Archived Events. Year. Date Event Details; Mar 01, 2024 at 10:30 AM EST Global Ship Lease … raymond\u0027s second hand worldWitrynaImpel's SEC filings can be viewed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov. Whom should I contact regarding investor inquiries? You can submit queries to Impel's investor relations department by contacting (206) 568-1466 or [email protected] . raymond\\u0027s rv repairWitrynaVice President, Investor Relations (281) 836-8360 [email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email … raymond\u0027s second hand world sarasota flWitryna6 wrz 2024 · Media Relations: Melyssa Weible Elixir Health Public Relations Phone: (1) 386-366-0616 Email: [email protected]. Investor Relations Christina Tartaglia Stern Investor Relations Phone: 212 ... raymond\\u0027s seasoningWitryna16 lip 2024 · About. About Nano Dimension Find our more about Nano Dimension. Leadership Team Nano Dimension Global Leadership Teams; Investor Relations Investor Relations site; Patents Patents awarded to Nano Dimension; Newsroom Recent News Coverage; Certifications & Compliance See our certifications and … simplify group updateWitrynaCorporate Profile. Alpine is a clinical-stage specialty pharmaceutical company focused on discovering and developing protein-based immunotherapies targeting the immune synapse to treat cancer and autoimmune/inflammatory diseases. Our proprietary Variant Immunoglobulin Domain™ (“vIgD™”) and Variant Tumor Necrosis Factor Domain™ … simplify group news